Association of hospital volume with conditional 90-day mortality after cystectomy: An analysis of the National Cancer Data Base

BJU International

Volumn 114, Issue 1, 2014, Pages 46-55

  Nielsen, Matthew E ^a,b,d   Mallin, Katherine ^e   Weaver, Mark A ^c   Palis, Bryan ^e   Stewart, Andrew ^e   Winchester, David P ^e   Milowsky, Matthew I ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c General Medicine and Clinical Epidemiology   (United States)

^d University of North Carolina at Chapel Hill   (United States)

^e National Cancer Data Base   (United States)

Author keywords

90 day mortality; bladder cancer; conditional survival; cystectomy; volume outcome

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER STAGING; CANCER SURVIVAL; CYSTECTOMY; DATA ANALYSIS; DATA BASE; FEMALE; HEALTH CARE QUALITY; HOSPITAL BED CAPACITY; HOSPITAL VOLUME; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; TREATMENT OUTCOME; VERY ELDERLY;

90-DAY MORTALITY; BLADDER CANCER; CONDITIONAL SURVIVAL; CYSTECTOMY; VOLUME-OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CYSTECTOMY; FEMALE; HOSPITALS, HIGH-VOLUME; HOSPITALS, LOW-VOLUME; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84903287283     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12566     Document Type: Article

References (36)

1. Clark P,. NCCN Guidelines for Bladder Cancer. NCCN Clinical Practice Guidelines in Oncology, Version 2.2012. 2012. Available at: http://www.nccn.org/ professionals/physician-gls/pdf/bladder.pdf. Accessed 24 April 2012
2. Gore JL, Litwin MS, Lai J, et al. Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst 2009; 102: 802-811
3. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346: 1128-1137
4. Finks JF, Osborne NH, Birkmeyer JD,. Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med 2011; 364: 2128-2137
5. Hollenbeck BK, Dunn RL, Miller DC, Daignault S, Taub DA, Wei JT,. Volume-based referral for cancer surgery: informing the debate. J Clin Oncol 2007; 25: 91-96
6. Hollenbeck BK, Taub DA, Miller DC, Dunn RL, Montie JE, Wei JT,. The regionalization of radical cystectomy to specific medical centers. J Urol 2005; 174 (4 Pt 1): 1385-1389; discussion 1389
7. Smaldone MC, Simhan J, Kutikov A, et al. Trends in regionalization of radical cystectomy in three large northeastern states from 1996 to 2009. Urol Oncol 2012; 31: 1663-1669
8. Konety BR, Dhawan V, Allareddy V, Joslyn SA,. Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project. J Urol 2005; 173: 1695-1700
9. Elting LS, Pettaway C, Bekele BN, et al. Correlation between annual volume of cystectomy, professional staffing, and outcomes: a statewide, population-based study. Cancer 2005; 104: 975-984
10. Barbieri CE, Lee B, Cookson MS, et al. Association of procedure volume with radical cystectomy outcomes in a nationwide database. J Urol 2007; 178 (4 Pt 1): 1418-1421; discussion 1421-2
11. Hollenbeck BK, Wei Y, Birkmeyer JD,. Volume, process of care, and operative mortality for cystectomy for bladder cancer. Urology 2007; 69: 871-875
12. Damhuis RA, Wijnhoven BP, Plaisier PW, Kirkels WJ, Kranse R, van Lanschot JJ,. Comparison of 30-day, 90-day and in-hospital postoperative mortality for eight different cancer types. Br J Surg 2012; 99: 1149-1154
13. Hollenbeck BK, Miller DC, Taub DA, et al. The effects of adjusting for case mix on mortality and length of stay following radical cystectomy. J Urol 2006; 176 (4 Pt 1): 1363-1368
14. Porter MP, Gore JL, Wright JL,. Hospital volume and 90-day mortality risk after radical cystectomy: a population-based cohort study. World J Urol 2011; 29: 73-77
15. Bilimoria KY, Stewart AK, Winchester DP, Ko CY,. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol 2008; 15: 683-690
16. Elixhauser A, Steiner C, Harris DR, Coffey RM,. Comorbidity measures for use with administrative data. Med Care 1998; 36: 8-27
17. Lieffers JR, Baracos VE, Winget M, Fassbender K,. A comparison of Charlson and Elixhauser comorbidity measures to predict colorectal cancer survival using administrative health data. Cancer 2011; 117: 1957-1965
18. Southern DA, Quan H, Ghali WA,. Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data. Med Care 2004; 42: 355-360
19. van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ,. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care 2009; 47: 626-633
20. Morgan TM, Barocas DA, Keegan KA, et al. Volume outcomes of cystectomy-is it the surgeon or the setting? J Urol 2012; 188: 2139-2144
21. Kulkarni GS, Urbach DR, Austin PC, Fleshner NE, Laupacis A,. Higher surgeon and hospital volume improves long-term survival after radical cystectomy. Cancer 2013; 119: 3546-3554
22. Zabor EC, Gonen M, Chapman PB, Panageas KS,. Dynamic prognostication using conditional survival estimates. Cancer 2013; 119: 3589-3592
23. Isbarn H, Jeldres C, Zini L, et al. A population based assessment of perioperative mortality after cystectomy for bladder cancer. J Urol 2009; 182: 70-77
24. Morgan TM, Keegan KA, Barocas DA, et al. Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy. J Urol 2011; 186: 829-834
25. Liu JH, Zingmond DS, McGory ML, et al. Disparities in the utilization of high-volume hospitals for complex surgery. JAMA 2006; 296: 1973-1980
26. Silber JH, Williams SV, Krakauer H, Schwartz JS,. Hospital and patient characteristics associated with death after surgery. A study of adverse occurrence and failure to rescue. Med Care 1992; 30: 615-629
27. Ghaferi AA, Birkmeyer JD, Dimick JB,. Variation in hospital mortality associated with inpatient surgery. N Engl J Med 2009; 361: 1368-1375
28. Ghaferi AA, Birkmeyer JD, Dimick JB,. Hospital volume and failure to rescue with high-risk surgery. Med Care 2011; 49: 1076-1081
29. Trinh VQ, Trinh QD, Tian Z, et al. In-hospital mortality and failure-to-rescue rates after radical cystectomy. BJU Int 2013; 112: E20-27
30. Donat SM, Shabsigh A, Savage C, et al. Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience. Eur Urol 2009; 55: 177-185
31. Hollenbeck BK, Daignault S, Dunn RL, Gilbert S, Weizer AZ, Miller DC,. Getting under the hood of the volume-outcome relationship for radical cystectomy. J Urol 2007; 177: 2095-2099; discussion 2099
32. Friese CR, Lake ET, Aiken LH, Silber JH, Sochalski J,. Hospital nurse practice environments and outcomes for surgical oncology patients. Health Serv Res 2008; 43: 1145-1163
33. BCBS. Blue Distinction Centers for Complex and Rare Cancers Program Selection Criteria for 2008/2009 Designations. 2009. Available at: http://www.bcbs.com/why-bcbs/blue-distinction/blue-distinction-complex-and-rare/ CRC-MidLevel-Criteria-101309.pdf. Accessed 20 July 2012
34. Cooperberg MR, Modak S, Konety BR,. Trends in regionalization of inpatient care for urological malignancies, 1988 to 2002. J Urol 2007; 178: 2103-2108; discussion 2108
35. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL,. Surgeon volume and operative mortality in the United States. N Engl J Med 2003; 349: 2117-2127
36. David KA, Milowsky MI, Ritchey J, Carroll PR, Nanus DM,. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. J Urol 2007; 178: 451-454